Budecort Respules Capsule is a medicine that is used for the treatment of Hormonal Problems, Parkinson’S Disease, Hyperprolactinemia, Acromegaly, Type 2 Diabetes Mellitus and other conditions.
Budecort Respules Capsule contains Budesonide as an active ingredient.
Budecort Respules Capsule works by reducing swelling and inflammation in the nose, throat, lungs or intestine.
Budecort Respules Capsule Uses
- Hormonal Problems
- Parkinson’S Disease
- Type 2 Diabetes Mellitus
Budecort Respules Capsule Working, Mechanism of Action and Pharmacology
Reducing swelling and inflammation in the nose, throat, lungs or intestine.
Budecort Respules Capsule – Composition and Active Ingredients
Budesonide (0.5 MG)
Budecort Respules Capsule – Side-effects
- Slow Growth In Children
Budecort Respules Capsule – Precautions & How to Use
Avoid drinking alcohol
Consult you doctor if you are pregnant or breastfeeding or had a miscarriage, ulcers, liver diseases, behavioural changes, migraine problems
Do not drive or operate heavy machinery
Exercise caution in case of fungal or bacterial infection
Inform your doctor in case of cardiovascular, hepatic and renal impairment, peptic ulcer, diabetes, diabetic retinopathy, concurrent use of oral contraceptives, history of psychotic disorders
Budecort Respules Capsule – Drug Interactions
- Ascorbic acid
Budecort Respules Capsule – Contraindications
- Acute infections uncontrolled by antimicrobial chemotherapy
Other important Information on Budecort Respules Capsule
Missing a dose
In case you miss a dose, take it as soon as you notice. If it is close to the time of your next dose, skip the missed dose and resume your dosing schedule. Do not take extra dose to make up for a missed dose. If you are regularly missing doses, consider setting an alarm or asking a family member to remind you. Please consult your doctor to discuss changes in your dosing schedule or a new schedule to make up for missed doses, if you have missed too many doses recently.
Overdosage of Budecort Respules Capsule
Do not take more than prescribed dose. Taking more medication will not improve your symptoms; rather they may cause poisoning or serious side-effects. If you suspect that you or anyone else who may have overdosed of Budecort Respules Capsule, please go to the emergency department of the closest hospital or nursing home. Bring a medicine box, container, or label with you to help doctors with necessary information.
Do not give your medicines to other people even if you know that they have the same condition or it seems that they may have similar conditions. This may lead to overdosage.
Storage of Budecort Respules Capsule
Store medicines at room temperature, away from heat and direct light. Do not freeze medicines unless required by package insert. Keep medicines away from children and pets.
Do not flush medications down the toilet or pour them into drainage unless instructed to do so. Medication discarded in this manner may contaminate the environment. Please consult your pharmacist or doctor for more details on how to safely discard Budecort Respules Capsule.
Expired Budecort Respules Capsule
Taking a single dose of expired Budecort Respules Capsule is unlikely to produce an adverse event. However, please discuss with your primary health provider or pharmacist for proper advice or if you feel unwell or sick. Expired drug may become ineffective in treating your prescribed conditions. To be on the safe side, it is important not to take expired drug. If you have a chronic illness that requires taking medicine constantly such as heart condition, seizures, and life-threatening allergies, you are much safer keeping in touch with your primary health care provider so that you can have a fresh supply of unexpired medications.
Budecort Respules Capsule – Packages and Strengths
Budecort Respules Capsule – Packages: 10 Respules
Budecort Respules Capsule – Strengths: 0.5MG
Warnings and Precautions
BUDECORT respules are to be used with a nebuliser, and only under the direction of a physician. The solution should not be injected or administered orally. Particular care is needed in patients who are being transferred from oral corticosteroids to BUDECORT respules. Special care is needed in patients with lung tuberculosis, and fungal and viral infections. Children who are on immunosuppressant drugs are more susceptible to infections than healthy children. Potential worsening of infections (e.g., existing tuberculosis, fungal, bacterial, viral, or parasitic infection; or ocular herpes simplex) can occur and hence is to be used with caution. Chicken pox and measles, for example, can take a more serious or even a fatal course in children on immunosuppressant corticosteroids. During long-term therapy, monitoring of hematological and adrenal function is advisable.
Non Steroid-Dependent Patients: A therapeutic effect is usually reached within 10 days. In patients with excessive mucus secretion in the bronchi, a short (about 2 weeks) additional oral corticosteroid regimen can be given initially. After the course of the oral drug, BUDECORT respules alone should be sufficient therapy.
Steroid-Dependent Patients: When transfer from oral corticosteroid to treatment with BUDECORT respules is initiated, the patient should be in a relatively stable phase. BUDECORT Respules is then given, in combination with the previously used oral steroid dose, for about 10 days. After that, the oral steroid dose should be gradually reduced (by, for example, 2.5 mg prednisolone or the equivalent each month), to the lowest possible level. In many cases, it is possible to completely substitute BUDECORT respules for the oral corticosteroid.
During transfer from oral therapy to nebulised budesonide, a generally lower systemic corticosteroid action will be experienced, which may result in the appearance of allergic or arthritic symptoms such as rhinitis, eczema and muscle and joint pain. Specific treatment should be initiated for these conditions. A general insufficient glucocorticosteroid effect should be suspected if, in rare cases, symptoms such as tiredness, headache, nausea and vomiting should occur. In these cases a temporary increase in the dose of oral glucocorticosteroids is sometimes necessary.
For more information visit us our website: www.medypharma.com